Is Everest Organics overvalued or undervalued?

Nov 15 2025 08:07 AM IST
share
Share Via
As of November 14, 2025, Everest Organics is fairly valued with a PE ratio of 62.63, an EV to EBITDA of 27.20, and a PEG ratio of 0.31, outperforming the Sensex with a year-to-date return of 41.84%, while its valuation is higher than Sun Pharma but lower than Divi's Lab.
As of 14 November 2025, Everest Organics has moved from an expensive to a fair valuation grade. The company is currently fairly valued based on its financial ratios, with a PE ratio of 62.63, an EV to EBITDA of 27.20, and a PEG ratio of 0.31. These ratios indicate that while the company has a high price-to-earnings ratio, its growth prospects may justify this valuation.

In comparison with peers, Everest Organics' PE ratio is significantly higher than that of Sun Pharma (36.49) and lower than Divi's Lab (69.65), which is categorized as very expensive. Additionally, its EV to EBITDA ratio is more favorable than that of Torrent Pharma (33.11), which is also very expensive. The recent performance of Everest Organics, with a year-to-date return of 41.84% compared to the Sensex's 8.22%, reinforces the notion that the stock is currently fairly valued in the market.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News